Nuclear Medicine

Vision

To be an excellent center in providing comprehensive, safe, updated and hospitable nuclear medicine services towards the community.

Mission

1. To provide a wide spectrum of nuclear medicine services to the population of Malaysia at a level compatible with internationally accepted standards.
2. To establish a nuclear medicine training centre in the hospital and strengthen the status as a national referral centre.
3. To establish a Masters' programme for doctors in the field of nuclear medicine and further courses for technologist, medical assistants and nurses.
4. To establish the basic nuclear medicine facility of both diagnostic and therapeutic services in each regional hospital in the country.

Objectives

1. To provide high quality of nuclear medicine service and expertise for patients or clients through teamwork and technology in accordance.
2. To ensure and equip every personnel in Nuclear Medicine Department with knowledge and skills to provide effective, efficient and safe services.
3. To encourage researches and audits to maintain quality of service.
4. To cultivate teamwork amongst personnel in Nuclear Medicine Department and clients with solicitous and professional attitude.
5. To increase number of specialists and technical skills in nuclear medical field via collaboration with external agencies such as IAEA, as well as, agreements with other countries for training.
6. To increase number of staffs with creating career and training opportunities within Malaysia and also other countries.
7. To improve and update equipments to enhance the quality of services and patients’ treatments.
8. To train medical officers and paramedics in nuclear medicine field.

Organisation Chart

Services

Services provided are classified under treatment and investigations:

1. Treatment
   1. Radioactive Iodine (Iodine-131) for :
      • Patients with relapse / resistant thyrotoxicosis
      • Thyroid cancer patients
   2. Radiosynovectomy using Yttrium-90, Rhenium-186 or Erbium-169 in haemophilia patients with bleeding in the joints (refractory haemarthrosis).
   3. Selective Internal Radiation Therapy (SIRT) with Yttrium-90 microspheres for patients with liver cancer and liver metastasis.
   4. Iodine-131 Metaiodobenzylguanidine (MIBG) therapy for cancers such as paraganglioma, pheochromocytoma and neuroblastoma treatments.
   5. Lutetium-177 therapy for prostate cancer.
   6. Yttrium-90 therapy for cystic craniopharyngioma.
   7. Follow-up cases.
2. Investigations
   1. Planar, SPECT and SPECT/CT
      1. Brain Scan
         • TRODAT
         • Eoilepsy
         • Brain perfusion and other
      2. Musculoskeletal scan
         • HDP
         • MDP
         • Triple Phase
      3. Cardiac scan
         • Perfusion
         • Viability
         • MUGA
         • Amyloidosis
      4. Lung scan
         • Ventilation and perfusion
         • Perfusion
      5. Renal scan
         • DTPA
         • MAG-3
         • DMSA
      6. Measurement of Glomerulsr Filtration Rate (GFR)
         • DTPA
         • EDTA
      7. Endocrine Scan
         • Tiroid
         • Paratiroid
         • MIBG
         • Iodin - 131
      8. Gastroenterology and hepatobiliary scan
         • Gastric emptying study
         • Oesophageal motility
         • Meckel’s diverticulum
         • Red blood cell tagging for intestinal bleed
         • SeHCAT for bile malabsorption
         • HIDA
         • Liver Scan
      9. Lymphatic scan
         • Sentinel lymph node mapping for breast cancer and melanoma
         • Lymphoscintigraphy
      10. Others
          • Pleural/peritoneal leak study
          • Liver-lung shunt study
          • Dacrayoscintigraphy for lacrimal gland
          • Salivary gland scintiography
   2. PET/CT Imaging
      1. Oncology
      2. Infection and Inflammation
      3. Brain
      4. Cardiology
      5. Paediatric

Service Schedule

Client Charter

We in Nuclear Medicine Department will ensure :

1. Every patient is given quality, patient oriented and timely service with emphasis on customer satisfaction. Priority is focused on customers who need immediate service. Services given in the department are based on the followings :
   1. Waiting time prior to seeing the doctor is less than 90 minutes.
   2. Patients with benign thyroid disease will receive radioiodine therapy ≤ 1 month.
2. The dignity and confidentiality of patient information is maintained.
3. Patient is provided with professional, honest and sincere service by a team of skilled, committed and compassionate personnel.
4. Patient will be given clear explanation of agreed procedures and treatments including the risk and options available.
5. To complete patient’s report/study results within 7 working days for normal cases and 2 days for urgent cases.

Related Information

Nuclear Medicine Department is located at the First Floor of the Institute of Radiotherapy and Oncology Building, while our Radioiodine Ward is located on the Ground Floor of the same building.

Forms Related to Nuclear Medicine Department:

1. Borang Permohonan Kajian/Pengimejan Radionuklid (Request form for radionuclide Imaging/study)
2. Request Form for Myocardial Perfusion Study
3. Request Form for PET/CT Imaging